U.S. Trends in Gender-Affirming Surgery Explored

Share this content:
U.S. Trends in Gender-Affirming Surgery Explored
U.S. Trends in Gender-Affirming Surgery Explored

THURSDAY, March 1, 2018 (HealthDay News) -- About 11 percent of patient encounters with a diagnosis code of transsexualism or gender identity disorder involve gender-affirming surgery, and more than half are not covered by an insurance plan, according to a study published online Feb. 28 in JAMA Surgery.

Joseph K. Canner, M.H.S., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues analyzed data from the National Inpatient Sample to examine the incidence and trends over time of gender-affirming surgical procedures. Demographics, health insurance plan, and type of surgery were compared between 2000-2005 and 2006-2011 and annually from 2012 to 2014.

The researchers identified 37,827 encounters with a diagnosis code of transsexualism or gender identity disorder. Overall, 10.9 percent of these encounters involved gender-affirming surgery; 56.3 percent of patients undergoing these procedures were not covered by a health insurance plan. There was an increase in the incidence of genital surgery over time, from 72 percent of patients who underwent gender-affirming procedures in 2000-2005 to 83.9 percent of patients who underwent gender-affirming procedures in 2006-2011. Compared with 2012-2013, in 2014 there was almost a three-fold increase in the number of patients seeking these procedures who were covered by Medicare or Medicaid (from 25 to 70).

"As coverage for these procedures increases, likely so will demand for qualified surgeons to perform them," the authors write.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

More U.S. Teens Are Vaping, but Use of Opioids, Alcohol Falling

More U.S. Teens Are Vaping, but Use of ...

About 37 percent of 12th graders said they had vaped within the previous 12 months

Type 2 Diabetes Risk Lower in Women With Active Migraine

Type 2 Diabetes Risk Lower in Women With ...

Prevalence of active migraine decreased linearly in the 24 years prior to diabetes diagnosis

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

Treatment costs less than extended-release naltrexone without negative impact on outcomes

is free, fast, and customized just for you!




Already a member?

Sign In Now »